EUVIMEDEUVIMED entdecken
Crossref

CaMKII phosphorylation promotes renal fibrosis in cisplatin induced chronic kidney disease via Smad 2/3 activation

Bhawna Tomar, Gaurav Jha, Divyansh Sharma, Sakshi Mishra, Radhika Kapoor, Srikanta Kumar Rath

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04790-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Bhawna Tomar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India. Hauptthemen laut MEDLINE: Cisplatin, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Renal Insufficiency, Chronic, Smad3 Protein. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, New Delhi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCalcium-Calmodulin-Dependent Protein Kinase Type 2Renal Insufficiency, ChronicSmad3 ProteinSmad2 ProteinAntineoplastic AgentsKidneyAnimalsMice, Inbred C57BLFibrosisPhosphorylationMaleCell LineMiceHumans

Stichwörter der Autor:innen

CKDCaMKIICisplatinFibrosisKN93

Substanzen

CisplatinCalcium-Calmodulin-Dependent Protein Kinase Type 2Smad3 ProteinSmad2 ProteinAntineoplastic AgentsSmad3 protein, mouseSmad2 protein, mouse

Autor:innen und Institutionen

  • Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India. skrath.research@gmail.com.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India. skrath.research@gmail.com.

Förderung

  • Council of Scientific and Industrial Research, New Delhi

Zitieren

APA

Tomar, B., Jha, G., Sharma, D., Mishra, S., Kapoor, R., & Rath, S. K. (2025). CaMKII phosphorylation promotes renal fibrosis in cisplatin induced chronic kidney disease via Smad 2/3 activation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04790-9

Vancouver

Tomar B, Jha G, Sharma D, Mishra S, Kapoor R, Rath SK. CaMKII phosphorylation promotes renal fibrosis in cisplatin induced chronic kidney disease via Smad 2/3 activation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04790-9

BibTeX
@article{Tomar2025,
  author = {Tomar, Bhawna and Jha, Gaurav and Sharma, Divyansh and Mishra, Sakshi and Kapoor, Radhika and Rath, Srikanta Kumar},
  title = {CaMKII phosphorylation promotes renal fibrosis in cisplatin induced chronic kidney disease via Smad 2/3 activation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04790-9}
}
Kostenlos starten →